Cargando…
Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152428/ https://www.ncbi.nlm.nih.gov/pubmed/33243960 http://dx.doi.org/10.4103/aja.aja_77_20 |
| _version_ | 1783698604035145728 |
|---|---|
| author | Lv, Jialu Lin, Jianqing |
| author_facet | Lv, Jialu Lin, Jianqing |
| author_sort | Lv, Jialu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8152428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81524282021-06-02 Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment Lv, Jialu Lin, Jianqing Asian J Androl Invited Research Highlight Wolters Kluwer - Medknow 2020-11-24 /pmc/articles/PMC8152428/ /pubmed/33243960 http://dx.doi.org/10.4103/aja.aja_77_20 Text en Copyright: ©The Author(s)(2020) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Invited Research Highlight Lv, Jialu Lin, Jianqing Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title | Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title_full | Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title_fullStr | Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title_full_unstemmed | Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title_short | Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment |
| title_sort | relugolix as a promising novel oral gnrh antagonist for prostate cancer treatment |
| topic | Invited Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152428/ https://www.ncbi.nlm.nih.gov/pubmed/33243960 http://dx.doi.org/10.4103/aja.aja_77_20 |
| work_keys_str_mv | AT lvjialu relugolixasapromisingnoveloralgnrhantagonistforprostatecancertreatment AT linjianqing relugolixasapromisingnoveloralgnrhantagonistforprostatecancertreatment |